According to Neogen's latest financial reports and stock price the company's current number of shares outstanding is 216,597,777. At the end of 2024 the company had 216,597,777 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2024 | 0.21 B | 0.09% |
2023 | 0.21 B | 0.13% |
2022 | 0.21 B | 100.79% |
2021 | 0.10 B |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | 387,000,000 | 78.67% | ๐บ๐ธ USA |
Becton Dickinson BDX | 290,113,000 | 33.94% | ๐บ๐ธ USA |
IDEXX Laboratories IDXX | 83,088,000 | -61.64% | ๐บ๐ธ USA |
Illumina ILMN | 158,000,000 | -27.05% | ๐บ๐ธ USA |
Danaher DHR | 739,800,000 | 241.55% | ๐บ๐ธ USA |
PerkinElmer
PKI | 126,285,000 | -41.70% | ๐บ๐ธ USA |
Pacific Biosciences
PACB | 267,121,000 | 23.33% | ๐บ๐ธ USA |
Meridian Bioscience VIVO | 43,749,000 | -79.80% | ๐บ๐ธ USA |